Clinical Trial

Porcine Derma for Soft Tissue Augmentation Around Implants

Study acronym: CT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Brief description of the study objectives The present study aims to evaluate the effectiveness of the porcine-derived collagen matrix Derma OsteoBiol® for peri-implant soft tissue augmentation. The objectives include: Measuring changes in soft tissue thickness (in 3D) in the buccal region of the treated implants; Analyzing patient-reported outcomes (PROMs), namely pain and impact on oral health-related quality of life; Monitoring the stability of peri-implant tissues and aesthetic parameters over a 12-month period.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-05-06
Trial Details
NCT Number NCT07436091
Lead Sponsor Universidade do Porto
Collaborators: Tecnoss Dental srl
Conditions Soft Tissue Augmentation Around Dental Implants
Enrollment 15 participants
Start Date 2026-04-01
Primary Completion 2027-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-05